BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34771477)

  • 1. 3p Arm Loss and Survival in Head and Neck Cancer: An Analysis of TCGA Dataset.
    Kim HAJ; Shaikh MH; Lee M; Zeng PYF; Sorgini A; Akintola T; Deng X; Jarycki L; Khan H; MacNeil D; Khan MI; Mendez A; Yoo J; Fung K; Lang P; Palma DA; Patel K; Mymryk JS; Barrett JW; Boutros PC; Morris LGT; Nichols AC
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles.
    Kim HAJ; Zeng PYF; Shaikh MH; Mundi N; Ghasemi F; Di Gravio E; Khan H; MacNeil D; Khan MI; Patel K; Mendez A; Yoo J; Fung K; Lang P; Palma DA; Mymryk JS; Barrett JW; Boutros PC; Nichols AC
    Oral Oncol; 2021 May; 116():105260. PubMed ID: 33725617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex disparities in head & neck cancer driver genes: An analysis of the TCGA dataset.
    Mundi N; Ghasemi F; Zeng PYF; Prokopec SD; Patel K; Kim HAJ; Di Gravio E; MacNeil D; Khan MI; Han MW; Shaikh M; Mendez A; Yoo J; Fung K; Gameiro SF; Palma DA; Mymryk JS; Barrett JW; Boutros PC; Nichols AC
    Oral Oncol; 2020 May; 104():104614. PubMed ID: 32146388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status.
    Ghasemi F; Prokopec SD; MacNeil D; Mundi N; Gameiro SF; Howlett C; Stecho W; Plantinga P; Pinto N; Ruicci KM; Khan MI; Yoo J; Fung K; Sahovaler A; Palma DA; Winquist E; Mymryk JS; Barrett JW; Boutros PC; Nichols AC
    JCI Insight; 2019 Jan; 4(1):. PubMed ID: 30626742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 3p loss in the progression and prognosis of head and neck cancer.
    Shaikh MH; Barrett JW; Khan MI; Kim HAJ; Zeng PYF; Mymryk JS; Nichols AC
    Oral Oncol; 2020 Aug; 109():104944. PubMed ID: 32828022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Host miRNA Hsa-miR-139-3p in HPV-16-Induced Carcinomas.
    Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
    Clin Cancer Res; 2017 Jul; 23(14):3884-3895. PubMed ID: 28143871
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers.
    Zhu G; Amin N; Herberg ME; Maroun CA; Wang H; Guller M; Gourin CG; Rooper LM; Vosler PS; Tan M; D'Souza G; Koch WM; Eisele DW; Seiwert TY; Fakhry C; Pardoll DM; Mandal R
    JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):70-79. PubMed ID: 34792560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.
    Morris LGT; Chandramohan R; West L; Zehir A; Chakravarty D; Pfister DG; Wong RJ; Lee NY; Sherman EJ; Baxi SS; Ganly I; Singh B; Shah JP; Shaha AR; Boyle JO; Patel SG; Roman BR; Barker CA; McBride SM; Chan TA; Dogan S; Hyman DM; Berger MF; Solit DB; Riaz N; Ho AL
    JAMA Oncol; 2017 Feb; 3(2):244-255. PubMed ID: 27442865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC).
    Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
    Mol Cell Biochem; 2018 Nov; 448(1-2):321-333. PubMed ID: 29455435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents.
    Pan C; Izreig S; Yarbrough WG; Issaeva N
    Cancers Head Neck; 2019; 4():3. PubMed ID: 31321084
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
    Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J; Tang LL; Ma J
    BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular landscape of head and neck cancer and implications for therapy.
    Farah CS
    Ann Transl Med; 2021 May; 9(10):915. PubMed ID: 34164549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
    Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
    Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the TCGA Dataset Reveals that Subsites of Laryngeal Squamous Cell Carcinoma are Molecularly Distinct.
    Sorgini A; Kim HAJ; Zeng PYF; Shaikh MH; Mundi N; Ghasemi F; Di Gravio E; Khan H; MacNeil D; Khan MI; Mendez A; Yoo J; Fung K; Lang P; Palma DA; Mymryk JS; Barrett JW; Patel KB; Boutros PC; Nichols AC
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33396315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune profiles in primary squamous cell carcinoma of the head and neck.
    Saloura V; Izumchenko E; Zuo Z; Bao R; Korzinkin M; Ozerov I; Zhavoronkov A; Sidransky D; Bedi A; Hoque MO; Koeppen H; Keck MK; Khattri A; London N; Kotlov N; Fatima A; Vougiouklakis T; Nakamura Y; Lingen M; Agrawal N; Savage PA; Kron S; Kline J; Kowanetz M; Seiwert TY
    Oral Oncol; 2019 Sep; 96():77-88. PubMed ID: 31422218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between FAT1 mutation and overall survival in patients with human papillomavirus-negative head and neck squamous cell carcinoma.
    Kim KT; Kim BS; Kim JH
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E2021-9. PubMed ID: 26876381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlate the
    Lyu H; Li M; Jiang Z; Liu Z; Wang X
    Comput Struct Biotechnol J; 2019; 17():1020-1030. PubMed ID: 31428295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
    Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.